BLRX
BioLineRx·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BLRX Filings
Filing Date
Form Description
Form Type
2025-11-24
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-24 · Earnings Call
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
2025-11-24
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-11-24 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-17
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-17 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-29
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-29 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-08-14
BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript
Earnings Call
2025-08-14 · Earnings Call
BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript
2025-08-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-14
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-08-14 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-07-25
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-07-25 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-06-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-06-30 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-05-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-05-30 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
